Category: Artificial Intelligence
AI Tool Sets New Standard in Diagnosing Rare Diseases
February 20, 2026
A new system, which consists of a large LLM and a network of agentic tools, outperformed several other models and human physicians [1]. Too rare to easily diagnose Rare diseases
Rejuve.AI Launches International Longevity Research Database
January 29, 2026
Roatán, Honduras — Rejuve.AI is activating the International Longevity Research Database (IRLDB) through its first real-world study cohort at the Longevity Biomarkers Competition and Summit, taking place February to March
An AI-Based System Has Found a Potential Longevity Drug
November 27, 2025
In a preprint published in bioRxiv, Prof. Vadim Gladyshev and a team of researchers have used an artificial intelligence-based system to discover a wide variety of potential interventions, including a
George Church on Building “Scientific Superintelligence”
November 21, 2025
George Church, a Harvard professor and a famed geroscientist, is also known as a serial entrepreneur who has co-founded dozens of biotech companies. While Church maintains that he’s involved in
Agentic AI Against Aging Hackathon
October 3, 2025
HackAging.ai is the global online hackathon at the intersection of Agentic AI and longevity science, bringing together researchers, founders, and engineers to accelerate solutions that extend healthy human lifespan. Turn
Joe Betts-Lacroix on Retro Bio and Its Recent AI Advancement
October 2, 2025
Retro Biosciences, one of the hottest startups in the longevity field, was founded about five years ago by the tech entrepreneur Joe Betts-Lacroix with a $180 million investment from his
AI Model Accurately Predicts Multiple Disease Risks
September 22, 2025
European scientists have created a GPT-based model that can predict the risk of more than a thousand diseases on par with single-disease tools and biomarker-based models [1]. Tell me the
AI Reveals a Hidden Effect in a Failed Alzheimer’s Trial
July 18, 2025
Scientists have created an AI model that stratifies Alzheimer’s patients into subgroups that progress slowly or rapidly. When applied to a real-world failed trial, it revealed a robust effect in
A Generative, Foundational AI Model for Genetics
February 24, 2025
The Arc Institute, a nonprofit research organization, has published a manuscript on its creation of Evo 2, an AI foundation model that is capable of both understanding and building full
AI Outperforms AI-Assisted Doctors in Diagnostic Reasoning
December 5, 2024
In a new study, ChatGPT 4.0 achieved significantly better diagnostic scores when evaluating complex cases than either unassisted human physicians or physicians who consulted the chatbot [1]. Bad news for
Can AI Predict Your Death?
December 4, 2024
Once confined to the realms of science fiction or relatively crude internet death calculators, AI-driven predictions about longevity are inching closer to reality. Questions about the accuracy and value of
AI in Longevity: The Reality Today
November 8, 2024
Back in 2006, a website called “The Death Clock” appeared on the internet, with a promise to answer one of life’s greatest questions: “When will I die?” Since then, over
InSilico Shares Details on AI-Generated Drug Candidate
March 14, 2024
In a new paper, InSilico has reported on its impressive success with a drug against idiopathic pulmonary fibrosis that was created by AI “from A to Z” and is currently
Heterochronic Parabiosis Extends the Lives of Mice
August 1, 2023
For the first time, scientists have shown that letting young and old mice share blood leads to a significant lifespan extension in the old mouse [1]. Rejuvenation by young blood
Genetically Engineering Cells to Respond to Electricity
July 31, 2023
A paper published today in Nature Metabolism has described a method of genetically engineering cells to respond to electrical stimuli, allowing for on-demand gene expression. Finding a better trigger Despite
AI Tool Sets New Standard in Diagnosing Rare Diseases
February 20, 2026
A new system, which consists of a large LLM and a network of agentic tools, outperformed several other models and human physicians [1]. Too rare to easily diagnose Rare diseases can be notoriously hard to diagnose. Patients average over 5 years to receive a correct diagnosis,
Rejuve.AI Launches International Longevity Research Database
January 29, 2026
Roatán, Honduras — Rejuve.AI is activating the International Longevity Research Database (IRLDB) through its first real-world study cohort at the Longevity Biomarkers Competition and Summit, taking place February to March 2026 as part of the Infinite Games in Roatán, Honduras. The IRLDB is being activated through
An AI-Based System Has Found a Potential Longevity Drug
November 27, 2025
In a preprint published in bioRxiv, Prof. Vadim Gladyshev and a team of researchers have used an artificial intelligence-based system to discover a wide variety of potential interventions, including a drug that significantly improves biomarkers of frailty in mice. Repurposing previous data Previous research efforts have
George Church on Building “Scientific Superintelligence”
November 21, 2025
George Church, a Harvard professor and a famed geroscientist, is also known as a serial entrepreneur who has co-founded dozens of biotech companies. While Church maintains that he’s involved in them all, one company has been seeing an unusual amount of his attention: Lila Sciences, where
Agentic AI Against Aging Hackathon
October 3, 2025
HackAging.ai is the global online hackathon at the intersection of Agentic AI and longevity science, bringing together researchers, founders, and engineers to accelerate solutions that extend healthy human lifespan. Turn two weeks into a job, a useful tool, a collaboration, or a company. The event is
Joe Betts-Lacroix on Retro Bio and Its Recent AI Advancement
October 2, 2025
Retro Biosciences, one of the hottest startups in the longevity field, was founded about five years ago by the tech entrepreneur Joe Betts-Lacroix with a $180 million investment from his friend Sam Altman, the CEO of OpenAI. Despite its hefty war chest, the company initially pursued
AI Model Accurately Predicts Multiple Disease Risks
September 22, 2025
European scientists have created a GPT-based model that can predict the risk of more than a thousand diseases on par with single-disease tools and biomarker-based models [1]. Tell me the future! For millennia, people have wanted to know what health events await them in the future.
AI Reveals a Hidden Effect in a Failed Alzheimer’s Trial
July 18, 2025
Scientists have created an AI model that stratifies Alzheimer’s patients into subgroups that progress slowly or rapidly. When applied to a real-world failed trial, it revealed a robust effect in the former subgroup [1]. Stratify and conquer Drugs don’t work for everyone equally. Unfortunately, clinical trials
A Generative, Foundational AI Model for Genetics
February 24, 2025
The Arc Institute, a nonprofit research organization, has published a manuscript on its creation of Evo 2, an AI foundation model that is capable of both understanding and building full genomes of organisms. A new step in understanding biology The authors of this paper, a group
AI Outperforms AI-Assisted Doctors in Diagnostic Reasoning
December 5, 2024
In a new study, ChatGPT 4.0 achieved significantly better diagnostic scores when evaluating complex cases than either unassisted human physicians or physicians who consulted the chatbot [1]. Bad news for human doctors? For millions of people, chatbots powered by large language models (LLMs) have quickly become
Can AI Predict Your Death?
December 4, 2024
Once confined to the realms of science fiction or relatively crude internet death calculators, AI-driven predictions about longevity are inching closer to reality. Questions about the accuracy and value of these forecasts remain. In recent years, researchers and companies around the globe have been pursuing answers
AI in Longevity: The Reality Today
November 8, 2024
Back in 2006, a website called “The Death Clock” appeared on the internet, with a promise to answer one of life’s greatest questions: “When will I die?” Since then, over 60 million people have used the site, which gives a somewhat grim countdown to the day
InSilico Shares Details on AI-Generated Drug Candidate
March 14, 2024
In a new paper, InSilico has reported on its impressive success with a drug against idiopathic pulmonary fibrosis that was created by AI “from A to Z” and is currently in Phase 2 trials [1]. AI against aging Many people in the longevity community hope that
Heterochronic Parabiosis Extends the Lives of Mice
August 1, 2023
For the first time, scientists have shown that letting young and old mice share blood leads to a significant lifespan extension in the old mouse [1]. Rejuvenation by young blood Since the dawn of civilization, young blood has been credited with healing and rejuvenating powers, and
Genetically Engineering Cells to Respond to Electricity
July 31, 2023
A paper published today in Nature Metabolism has described a method of genetically engineering cells to respond to electrical stimuli, allowing for on-demand gene expression. Finding a better trigger Despite its futuristic outlook, this line of research is built upon previous work. The idea of an